Management of Intracerebral Hemorrhage
Intracerebral hemorrhage requires immediate aggressive medical management focused on preventing hematoma expansion through rapid blood pressure control to systolic <140 mmHg, immediate reversal of anticoagulation, and intensive monitoring in a neuroscience critical care unit. 1, 2
Emergency Assessment and Diagnosis
- Obtain non-contrast head CT immediately upon arrival to distinguish ICH from ischemic stroke—this is the gold standard for identifying acute hemorrhage 3, 2
- Perform baseline severity scoring using Glasgow Coma Scale (GCS) or NIH Stroke Scale as part of initial evaluation 1, 2
- Consider CT angiography to identify patients at risk for hematoma expansion, particularly looking for the "spot sign" which predicts ongoing bleeding 2
- Recognize that over 20% of patients deteriorate by ≥2 GCS points between prehospital assessment and ED arrival, and another 15-23% continue deteriorating in the first hours after hospital arrival 1, 3
Acute Blood Pressure Management
Lower systolic blood pressure to 140 mmHg immediately in patients presenting with SBP 150-220 mmHg without contraindications—this is safe and improves functional outcomes 2, 4
- Avoid rapid drops ≥60 mmHg within 1 hour, as this may worsen outcomes 5
- Target SBP as low as 120-130 mmHg for optimal functional outcomes in mild-to-moderate severity ICH 5
- Minimize blood pressure variability during the first 24 hours to prevent hematoma expansion 5
- Begin BP control measures immediately after ICH onset, as hematoma expansion commonly occurs within the first few hours 2
Reversal of Anticoagulation
Reverse anticoagulation immediately in all patients on anticoagulants, as this reduces hematoma expansion risk and may improve outcomes 5
For Vitamin K Antagonists (Warfarin):
- Administer prothrombin complex concentrate (PCC) as first-line therapy—this is preferred over fresh frozen plasma for rapid INR correction 2, 5
- Give intravenous vitamin K concurrently 2
- Withhold the warfarin 2
For Direct Oral Anticoagulants:
- Dabigatran: Administer idarucizumab 4, 5
- Factor Xa inhibitors (rivaroxaban, apixaban, edoxaban): Use andexanet alfa where available, or PCC as alternative 4, 5
For Thrombocytopenia or Platelet Dysfunction:
- Administer platelets to maintain platelet count above 50×10⁹/L in patients with ongoing bleeding 3
Intensive Care Unit Management
Admit all ICH patients to an intensive care unit or dedicated stroke unit with physician and nursing neuroscience acute care expertise 2, 6
Intracranial Pressure Management:
- Monitor ICP in patients with GCS ≤8, hydrocephalus, or clinical evidence of transtentorial herniation 3, 4
- Use osmotic agents (mannitol or hypertonic saline) to produce hyperosmolality and euvolemia in patients with elevated ICP 4
- Avoid acetazolamide in ICH management 4
- Use 0.9% saline as the crystalloid of choice to prevent worsening cerebral edema 4
- Avoid medications that cause cerebral vasodilation or increase cerebral blood volume, as these worsen intracranial compliance and can precipitate herniation 4
Prevention of Secondary Complications:
- Initiate intermittent pneumatic compression on the day of hospital admission for venous thromboembolism prophylaxis 2
- Begin pharmacological thromboprophylaxis within 24 hours after bleeding has been controlled 3
- Perform formal dysphagia screening before initiating oral intake to reduce pneumonia risk 2
- Treat clinical seizures with antiseizure medications 2
- Monitor and manage glucose levels, avoiding both hyperglycemia and hypoglycemia 2
- Manage fever aggressively as part of neuroprotective care 3
Surgical Management
Cerebellar Hemorrhage:
Perform immediate surgical evacuation in patients with cerebellar hemorrhage who are deteriorating neurologically or have brainstem compression and/or hydrocephalus from ventricular obstruction 3, 2
- This is the clearest surgical indication in ICH management 1, 2
- Do not use ventricular catheter alone instead of cerebellar hematoma evacuation, especially in patients with compressed cisterns 1
Supratentorial ICH:
- For most patients with supratentorial ICH, the usefulness of surgery is uncertain (Class IIb evidence) 3
- Consider early surgery for patients with lobar hemorrhages, GCS 9-12, and hematomas extending to within 1 cm of the cortical surface 1, 3, 2
- Minimally invasive procedures for hematoma removal show potential to improve outcomes in lobar ICH and deserve further evaluation 5, 7
Hydrocephalus Management:
- Perform external ventricular drainage (EVD) for patients with hydrocephalus or ventricular obstruction 4
- Consider intraventricular fibrinolysis with or without lumbar drainage for intraventricular hemorrhage, though this remains investigational 1, 8
Prognostication and Goals of Care
- Hematoma volume and admission GCS score are the most powerful predictors of 30-day mortality 3
- Avoid early do-not-resuscitate orders or withdrawal of active care in the first 24-48 hours, as early prognostication is difficult and often inaccurate 5, 6
- Use formal prognostic tools to offer information to patients and families rather than clinical gestalt alone 6
- Recognize that most patients present with small ICHs that are readily survivable with good medical care 1, 3
Contraindicated Interventions
Do not administer corticosteroids in ICH management—these are specifically contraindicated 2, 4
Rehabilitation
Provide access to multidisciplinary rehabilitation services for all ICH patients 2
Common Pitfalls
- Delaying neuroimaging leads to missed opportunities for intervention during the critical window when hematoma expansion occurs 2
- Failing to correct coagulopathy rapidly in anticoagulated patients allows continued hematoma expansion and worse outcomes 2
- Overlooking secondary causes of ICH (vascular malformations, tumors, cerebral venous thrombosis) in patients with atypical presentations or unusual hemorrhage locations 2
- Premature prognostication leading to early withdrawal of care in potentially salvageable patients 5, 6